ANL 24.19 Increased By ▲ 1.74 (7.75%)
ASC 15.65 Decreased By ▼ -0.31 (-1.94%)
ASL 21.90 Decreased By ▼ -0.50 (-2.23%)
BOP 8.47 Increased By ▲ 0.07 (0.83%)
BYCO 8.82 Increased By ▲ 0.02 (0.23%)
FCCL 17.35 Decreased By ▼ -0.56 (-3.13%)
FFBL 24.60 Decreased By ▼ -0.35 (-1.4%)
FFL 17.30 Decreased By ▼ -0.02 (-0.12%)
FNEL 8.36 Increased By ▲ 0.13 (1.58%)
GGGL 21.26 Decreased By ▼ -0.17 (-0.79%)
GGL 41.18 Decreased By ▼ -0.02 (-0.05%)
HUMNL 6.88 Decreased By ▼ -0.17 (-2.41%)
JSCL 21.00 Increased By ▲ 0.65 (3.19%)
KAPCO 37.71 Decreased By ▼ -0.25 (-0.66%)
KEL 3.56 Increased By ▲ 0.01 (0.28%)
MDTL 2.98 Decreased By ▼ -0.01 (-0.33%)
MLCF 35.70 Decreased By ▼ -0.97 (-2.65%)
NETSOL 152.38 Increased By ▲ 0.98 (0.65%)
PACE 5.74 Decreased By ▼ -0.11 (-1.88%)
PAEL 30.71 Decreased By ▼ -0.39 (-1.25%)
PIBTL 9.26 Decreased By ▼ -0.05 (-0.54%)
POWER 7.72 Decreased By ▼ -0.19 (-2.4%)
PRL 19.95 Decreased By ▼ -0.30 (-1.48%)
PTC 10.25 Decreased By ▼ -0.09 (-0.87%)
SILK 1.65 Decreased By ▼ -0.06 (-3.51%)
SNGP 45.10 Increased By ▲ 0.43 (0.96%)
TELE 22.59 Increased By ▲ 0.39 (1.76%)
TRG 176.10 Increased By ▲ 1.50 (0.86%)
UNITY 35.00 Decreased By ▼ -0.60 (-1.69%)
WTL 3.16 Decreased By ▼ -0.02 (-0.63%)
BR100 4,954 Decreased By ▼ -7.14 (-0.14%)
BR30 24,372 Decreased By ▼ -51.03 (-0.21%)
KSE100 46,475 Decreased By ▼ -53.07 (-0.11%)
KSE30 18,393 Decreased By ▼ -29.04 (-0.16%)

Coronavirus
HIGH Source: covid.gov.pk
Pakistan Deaths
27,327
8124hr
Pakistan Cases
1,227,905
1,89724hr
4.1% positivity
Sindh
451,448
Punjab
423,670
Balochistan
32,772
Islamabad
104,348
KPK
171,589
World

Mixed AstraZeneca-Pfizer shot boosts COVID antibody level

  • The study involved 499 medical workers - 100 receiving mixed doses, 200 taking two doses of the Pfizer/BioNTech shot and the remainder getting two AstraZeneca shots
26 Jul 2021

SEOUL: A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed.

The study involved 499 medical workers - 100 receiving mixed doses, 200 taking two doses of the Pfizer/BioNTech shot and the remainder getting two AstraZeneca shots.

All showed neutralizing antibodies, which prevent the virus from entering cells and replicating, and the result of the mixed schedule of vaccines showed similar amounts of neutralizing antibodies found from the group that received two Pfizer shots.

AstraZeneca searching for vaccines for virus-hit Southeast Asia

A British study last month showed similar results - an AstraZeneca shot followed by Pfizer produced the best T-cell responses, and a higher antibody response than Pfizer followed by AstraZeneca.

The data provides further support for the decision of several countries to offer alternatives to AstraZeneca as a second shot after the vaccine was linked to rare blood clots.

The South Korean study also analysed neutralizing activity against major variants of concern, the Korea Disease Control and Prevention Agency (KDCA) said.

None of the groups demonstrated reduced neutralising activity against the Alpha variant, first identified in Britain, but the neutralization titre decreased by 2.5 to 6 fold against Beta, Gamma and Delta, first detected in South Africa, Brazil and India respectively.

Comments

Comments are closed.